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Oral cancer makes up 1%-2% of all cancers that may arise in the body. The majority of oral cancers consists of 
squamous cell carcinomas. Oral cancer carries a considerable mortality rate, being mainly dependent on the stage 
of the disease at admission. Worldwide some 50% of the patients with oral cancer present with advanced disease. 
There are several ways of trying to diagnose oral cancer in a lower tumor stage, being 1) mass screening or screen-
ing in selected patients, 2) reduction of patients’ delay, and 3) reduction of doctors’ delay.
Oral cancer population-based screening (“mass screening”) programs do not meet the guidelines for a successful out-
come. There may be some benefit when focusing on high-risk groups, such as heavy smokers and heavy drinkers.
Reported reasons for patients’ delay range from fear of a diagnosis of cancer, limited accessibility of primary 
health care, to unawareness of the possibility of malignant oral diseases. Apparently, information campaigns in 
news programs and TV have little effect on patients’ delay. Mouth self-examination may have some value in re-
ducing patients’ delay.
Doctors’ delay includes dentists’ delay and diagnostic delay caused by other medical and dental health care profes-
sionals. Doctors’ delay may vary from almost zero days up to more than six months. 
Usually, morbidity of cancer treatment is measured by quality of life (QoL) questionnaires. In the past decades this 
topic has drawn a lot of attention worldwide. It is a challenge to decrease the morbidity that is associated with the 
various treatment modalities that are used in oral cancer without substantially compromising the survival rate. 
Smoking cessation contributes to reducing the risk of oral cancers, with a 50% reduction in risk within five years. 
Indeed, risk factor reduction seems to be the most effective tool in an attempt to decrease the morbidity and mor-
tality of oral cancer.
Key words: Oral cancer, early diagnosis, quality of life.
van der Waal I. Are we able to reduce the mortality and morbidity of oral 
cancer; some considerations. Med Oral Patol Oral Cir Bucal. 2013 Jan 
1;18 (1):e33-7.   
 http://www.medicinaoral.com/medoralfree01/v18i1/medoralv18i1p33.pdf
Article Number: 18486          http://www.medicinaoral.com/
© Medicina Oral S. L. C.I.F. B 96689336 - pISSN 1698-4447 - eISSN: 1698-6946
eMail:  medicina@medicinaoral.com 
Indexed in: 
Science Citation Index Expanded
Journal Citation Reports
Index Medicus, MEDLINE, PubMed




Med Oral Patol Oral Cir Bucal. 2013 Jan 1;18 (1):e33-7.                                                                                                                                                              Mortality and morbidity of oral cancer
e34
Introduction
Oral cancer makes up approximately 1%-2% of all 
cancers that may arise in the body. The great majority 
of oral cancers consists of squamous cell carcinomas. 
The remaining cancer types include malignant salivary 
gland tumors, sarcomas of the soft tissues and the jaw 
bones, melanoma, malignant odontogenic tumors, lym-
phoreticular malignancies, and metastases from tumors 
located elsewhere in the body.
Oral cancer carries a considerable mortality rate, be-
ing mainly dependent on the stage of the disease at ad-
mission. The five-year survival rate of stage I cancer, 
including the various subsites such as borders of the 
tongue, floor of the mouth, cheek, and gums amounts 
approximately 80%, while the five-year survival of pa-
tients with advanced disease (stages III/IV) is approxi-
mately 20%. Worldwide some 50% of the patients with 
oral cancer present with advanced disease (1). Early di-
agnosis, therefore, seems key. Even more important is 
to prevent oral cancer, which can be achieved mainly by 
cessation of heavy tobacco and alcohol consumption.
In a previous paper on early diagnosis of oral cancer 
it has been mentioned that the adjective “early” can be 
used in three ways, being 1) early in the process of car-
cinogenesis, 2) early in the meaning of a relatively small 
size of the cancer at the time of diagnosis, and 3) early 
in the meaning of a short interval between the time of 
symptoms and the time of diagnosis (2).
At present, there are no serological markers or any other 
laboratory studies that are helpful in detecting primary 
oral squamous cell carcinoma (OSCC) in a stage where 
there is no measurable tumor or precursor yet (3). Be-
sides, displacing a diagnosis of cancer to an earlier stage 
of the carcinogenesis may prolong the survival time 
without actually influencing the time of death. This pit-
fall has been termed “lead-time-bias” (4).
As mentioned earlier, small stage OSCC carries a bet-
ter survival rate than large stage OSCC. It is generally 
believed that patients with a short diagnostic delay (pa-
tients’ and doctors’ delay together) carry a better prog-
nosis than those with a long diagnostic delay. However, 
the assumed better survival rate has not been confirmed 
in a few studies on this subject from the United King-
dom (5,6). Furthermore, early detection and treatment 
of oral precancerous lesions, particularly leukoplakia 
and erythroplakia, may not truly prevent the future de-
velopment of OSCC at the siteof the treated lesion or 
elsewhere in the oral cavity (7).
Reducing the mortality of oral cancer by detec-
tion oral cancer in a less advanced stage
There are several ways of trying to diagnose oral can-
cer in a lower tumor stage, being 1) mass screening or 
screening in selected patients, 2) reduction of patients’ 
delay, and 3) reduction of doctors’ delay.
-Oral cancer population-based screening (“mass screen-
ing”) programs do not meet the epidemiological guide-
lines for a successful outcome and are not considered 
to be cost-effective in its current forms (8). There may 
be some benefit when focusing screening programs on 
high-risk groups, such as heavy smokers and heavy 
drinkers (9), patients with previous cancer in the head 
and neck area (10), and patients with previous cancer 
outside the head and neck area (11).
In a study in Japan the results of oral screening as an in-
tegral part of general health screening in adults over 40 
years of age have been reported (12). Some 26% of the 
population participated in the general health screening 
program and almost all of these entered the oral cancer 
screening program performed by dentists. The results 
of the oral screening are shown in (Table 1). These re-
sults do not allow to draw any conclusions about the 
Main findings in 19.000 
subjects 
Cancer   9 
Leukoplakia  74 
Erythroplakia   4 
Lichen planus 102 
Other 518 
Total  707 
Table 1. Oral cancer screening 
as part of a free annual general 
health screening program in Japan 
(slightly modified) (12).
possible positive effect of the oral cancer screening pro-
gram on morbidity and mortality. It merely shows that 
subjects who participate in a general health screening 
program almost without exception want to participate 
in an oral cancer screening program. Furthermore, no 
information has been provided in the Japanese study 
about the costs involved in the general health and oral 
cancer screening program.
-Reduction of patients’ delay may reduce morbidity and 
may decrease the mortality rate. The average patients’ de-
lay in oral cancer diagnosis is approximately three months 
(13). Reported reasons for such delay range from fear of 
a diagnosis of cancer, limited accessibility of primary 
health care for patients with a low social economic status 
to, above all, unawareness of the possibility of malignant 
disease in case of a symptomatic oral lesion (14).
Apparently, information campaigns in news programs 
and TV have little effect on patients’ delay (15). Few e-
ducational materials for the general public are available 
that are specifically directed to oral cancer and those that 
are available may be written at too a high grade level for 
the general public (16). In 2001 a leaflet on oral cancer 
directed at dental patients has been published (Table 2) 
(17). To the best of our knowledge the effectiveness of 
Med Oral Patol Oral Cir Bucal. 2013 Jan 1;18 (1):e33-7.                                                                                                                                                              Mortality and morbidity of oral cancer
e35
this leaflet has not been examined yet. Rogers et al. re-
ported the results of a survey among 71 oral and oropha-
ryngeal cancer patients (18). A nonhealing ulcer or sore 
was reported as the most common first symptom; some 
50% interpreted their symptoms as something minor, not 
being aware of oral cancer. Altogether, there is a lack of 
evidence that any public intervention has a measurable 
impact on oral cancer incidence and morbidity other than 
tobacco and alcohol consumption control (19).
-Mouth self-examination
In an Editorial by Sarode et al. the potential role of mouth 
self-examination has been emphasized as a method for 
reducing the morbidity and mortality rate of oral cancer 
(20). In a study in India, using a brochure describing the 
risk factors of oral cancer and precancer, and also show-
ing the appearance of these lesions by photographs, 247 
patients out of 8.000 patients who practiced mouth self-
examination reported to the clinics (21). The findings in 
these 247 patients have been presented in (Table 3). The 
authors advised to further examine the possible value 
of mouth self-examination in a randomized controlled 
study, including much larger study groups and observ-
ing a follow-up period of at least ten years before being 
able to demonstrate a possibly significant reduction of 
the mortality rate. In a differently structured study, also 
conducted in India, the reliability of the results of mouth 
self-examination in some 34.000 persons were subse-
quently checked by health care workers (22). The results 
are shown in (Table 4). Apparently, mouth self-exami-
nation had a low sensitivity of 18%, while the specificity 
was almost 100%. A somewhat similar experience was 
observed in another study in the United Kingdom (23).
-Reduction of doctors’ delay in the diagnosis of oral 
cancer
Doctors’ delay includes dentists’ delay and also diag-
nostic delay caused by other medical and dental health 
care professionals. A dentist may not encounter an av-
erage of more than 5-10 patients with oral cancer dur-
ing his professional life, while this number may be even 
less for medical practitioners. Also in view of the rather 
nonspecific symptoms and the diversity of clinical pres-
entations of oral cancer, it should be no surprise that 
there is often a considerable delay in suspecting ma-
lignancy in case of oral cancer. Such delay may vary 
from almost zero days up to more than six months with 
a mean of three to five weeks (13,24). Doctors’ delay of 
more than five weeks occurs significantly more often in 
patients under the age of 40 years. Klosa et al. reported 
a discrepancy in the dentists opinions and practices in 
routine oral examination for cancerous and precancer-
ous lesions (25). 
Not surprisingly, it has been shown by Patton et al. that 
dental health professionals are more adequately trained 
to perform oral cancer examination than physicians 
(26). Physicians, indeed, felt a need for improvement of 
their oral examination skills. In a study from the United 
Kingdom medical professionals were questioned about 
possible barriers to conduct oral examinations for can-
cer (27). Barriers mentioned to perform such examina-
tions were lack of training, lack of knowledge, lack of 
equipment, lack of time, and the notion that dentists are 
the ones who are primarily responsible for oral cancer 
detection. The latter notion was also mentioned in a 
study among primary health care professionals (28).
?  A color change in the oral tissues (whitish or red spots, for example) 
? A lump, thickening, rough spot, crust or small eroded area 
? A sore that bleeds easily or does not heal 
? Pain, tenderness or numbness anywhere in the mouth or on the lips 
? Difficulty in chewing, swallowing, speaking or moving the jaw or tongue 
? Changes in the voice 
? A change in the way your teeth fit together 
    In addition, watch for changes beyond the mouth that could signal oral cancer 
? Drastic weight loss 
? A lump or mass in your neck 
Table 2. Oral cancer: what to look for? A leaflet for dental patients 
(17).
? 9000 households received a brochure 
? Directed at smokers and/or aged > 30 years 
? 22.000 eligible subjects 
? 8000 practiced MSE 
? 247 reported to the clinics for an oral examination 
-   seven (3%) had oral cancer (six stage I) 
-   eighty-five (34%) had precancerous lesions, including submucous fibrosis 
-   remaining participants had benign lesions or anatomical variations 
Table 3. Mouth self-examination in India (21).
Characteristics of lesions 
Detected by SE 
(number) 
Detected by HWs 
(number) 
% of lesions detected by SE 
as compared to that of HWs 
White patch 23 173 12.7 
Red patch 11 9 66.7 
Non healing ulcer 10 14 42.9 
Difficulty in opening the mouth 4 12 25.0 
Other oral symptoms (e.g. burning sensation) 6 11 18.2 
Total 54 219 17.8 
Table 4. Characteristics of oral lesions by self-examination and health worker examination (n=34.000) (22).
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Reducing the morbidity of oral cancer treatment
Morbidity of oral cancer treatment may be related to sur-
gery, radiotherapy, chemotherapy and other treatment mo-
dalities and treatment related modalities, including dental 
rehabilitation. Usually, morbidity is measured by quality of 
life (QoL) questionnaires. Furthermore, QoL includes not 
only physical and mental health, but also factors such as 
family and leisure activities. The WHO has defined QoL 
as “Individual  perceptions of their position in the context 
of the culture and value systems in which they live and in 
relation to their goals and concerns” (29).
In a study among 561 patients treated by surgery for 
oral and oropharyngeal cancer six groups were identi-
fied arranging from T1T2 oral cancer, no free flap, no 
RT to T3T4 oral cancer, free flap + RT and, as a separate 
group, oropharyngeal cancer (30).  The items that have 
been scored are listed in table 5. The questionnaires 
have been completed at the time of admission and at 6 
and 12 months after completion of treatment. Not sur-
prisingly, the patients who do best are those with small 
oral cancers, not needing free-flap surgery and not hav-
ing radiotherapy. This finding was confirmed in a study 













Table 5. Items of a QoL questionnaire used 
in patients treated by primary surgery for 
oral and oropharyngeal cancer (30).
years obtained higher QoL scores. De Wit et al. stud-
ied donor site morbidity of the fasciocutaneous radial 
forearm flap (32). Donor site morbidity measured by 
functional tests was limited but subjective self-ratings 
revealed complaints regarding cosmetics, sensibility 
and forearm disability.
In a study in the United Kingdom it was shown that can-
cer of the head and neck (HNC) has a serious impact 
on financial aspects of patients’ life. In a survey in The 
Netherlands it was shown that HNC survivors return to 
work within six months after treatment (33); oral dys-
function, loss of appetite, deteriorated social function-
ing, and high levels of anxiety were barriers for HNC 
survivors to return to work after treatment. In a study 
by Borggreven et al. is was shown that comorbidity has 
a major impact on patients treated for HNC (34). In Ver-
donck’s et al study is was shown that distress is often 
present in spouses and patients after treatment for HNC 
(35). Distress in patients was related to the presence of a 
feeding tube, speech and swallowing problems, less so-
cial contacts, a passive style of coping, and nonexpres-
sion of emotions. Handschel et al. emphasized the im-
pact of psychological treatment in HNC patients (36).
Langendijk et al. reported on the late treatment-related 
toxicity on quality of life among patients with HNC 
treated with radiotherapy. It was concluded that the 
development of new radiation-induced delivery tech-
niques should not only focus on reduction of the dose to 
the salivary glands, but also to anatomic structures that 
are involved in swallowing (37).
It is a challenge to decrease the morbidity that is associ-
ated with the various treatment modalities that are used 
in oral cancer without substantially compromising the 
survival rate. On the other hand, improving the survival 
rate by extended treatment may significantly increase 
the morbidity and, thereby, influence the quality of life 
in a negative way.
Prevention
It is obvious that cessation of tobacco and alcohol use 
results in a lower incidence of oral cancer. Smoking ces-
sation contributes to reducing the risk of oral cancers, 
with a 50% reduction in risk within five years (38); ten 
years after smoking cessation the risk approaches that 
for life-long nonsmokers.
There are numerous reports on cessation of smoking pro-
grams. An interesting overview of these studies is pro-
vided by Maillet et al (39). Tobacco cessation counseling 
can be performed by dentists and also by dental auxiliary 
personnel, such as dental hygienists (39). In Maillet’s et 
al study, the results have not been very encouraging, as 
shown in table 6. Only 2% of the patients stopped perma-
nently using tobacco. The authors announced to improve 
their program and to again evaluate the results.
Conclusions
Particularly risk factor reduction and perhaps also early 
detection of oral cancer and precancer will decrease the 
morbidity and mortality of oral cancer.
Table 6. Tobacco cessation counseling by dental hygienists. – 
Responses to survey questions among 132 dental patients (39).
*  Average quit time was 3.5 months.






1. Were you advised to quit tobacco usage? 90% 10% 
2.Were you advised of the health risks associated with tobacco use? 98% 2% 
3.Were information pamphlets provided to you?          51% 49% 
4.Were you provided with strategies to assist in the quitting process?   53% 47% 
5.After counseling, did you permanently quit using tobacco? 2% 98% 
6.(If not) Did you quit for any period of time?   22% 78% 
7.Were you taught self-examination techniques? 33% 67% 
8.(If yes) Do you do the self-examination?    65% 35% 
9.Was there any follow-up, by either a phone call or appointment 
   following your TCC*? 8% 92% 
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There should be ways to increase the awareness of 
the public about oral cancer and precancer, including 
knowledge about the risk factors. At present, the results 
of mouth self-examination are somewhat disappoint-
ing. Mass screening for oral cancer is regarded not to 
be cost-effective. Instead, screening of selected high 
risk groups may be worth to perform in an attempt to 
diagnose oral cancer in an earlier tumor stage, thereby 
allegedly reducing the morbidity and mortality rate.
Dentists and physicians should be continuously advised 
to attend programs that are directed at the early detec-
tion of oral cancer and precancer.
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